273 related articles for article (PubMed ID: 32174803)
1. NBOMes-Highly Potent and Toxic Alternatives of LSD.
Zawilska JB; Kacela M; Adamowicz P
Front Neurosci; 2020; 14():78. PubMed ID: 32174803
[TBL] [Abstract][Full Text] [Related]
2. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A Harmful Hallucinogen Review.
Kamińska K; Świt P; Malek K
J Anal Toxicol; 2021 Jan; 44(9):947-956. PubMed ID: 32128596
[TBL] [Abstract][Full Text] [Related]
3. Case series: toxicity from 25B-NBOMe--a cluster of N-bomb cases.
Gee P; Schep LJ; Jensen BP; Moore G; Barrington S
Clin Toxicol (Phila); 2016; 54(2):141-6. PubMed ID: 26621342
[TBL] [Abstract][Full Text] [Related]
4. Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.
Elmore JS; Decker AM; Sulima A; Rice KC; Partilla JS; Blough BE; Baumann MH
Neuropharmacology; 2018 Nov; 142():240-250. PubMed ID: 29501528
[TBL] [Abstract][Full Text] [Related]
5. Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT
Eshleman AJ; Wolfrum KM; Reed JF; Kim SO; Johnson RA; Janowsky A
Biochem Pharmacol; 2018 Dec; 158():27-34. PubMed ID: 30261175
[TBL] [Abstract][Full Text] [Related]
6. Evolution of the NBOMes: 25C- and 25B- Sold as 25I-NBOMe.
Laskowski LK; Elbakoush F; Calvo J; Exantus-Bernard G; Fong J; Poklis JL; Poklis A; Nelson LS
J Med Toxicol; 2015 Jun; 11(2):237-41. PubMed ID: 25387562
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of use and acute toxicity associated with the use of NBOMe drugs.
Wood DM; Sedefov R; Cunningham A; Dargan PI
Clin Toxicol (Phila); 2015 Feb; 53(2):85-92. PubMed ID: 25658166
[TBL] [Abstract][Full Text] [Related]
8. Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe.
Tang MH; Ching CK; Tsui MS; Chu FK; Mak TW
Clin Toxicol (Phila); 2014 Jun; 52(5):561-5. PubMed ID: 24779864
[TBL] [Abstract][Full Text] [Related]
9. Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).
Rickli A; Luethi D; Reinisch J; Buchy D; Hoener MC; Liechti ME
Neuropharmacology; 2015 Dec; 99():546-53. PubMed ID: 26318099
[TBL] [Abstract][Full Text] [Related]
10. Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper.
Poklis JL; Raso SA; Alford KN; Poklis A; Peace MR
J Anal Toxicol; 2015 Oct; 39(8):617-23. PubMed ID: 26378135
[TBL] [Abstract][Full Text] [Related]
11. The psychoactive drug 25B-NBOMe recapitulates rhabdomyolysis in zebrafish larvae.
Kawahara G; Maeda H; Kikura-Hanajiri R; Yoshida KI; Hayashi YK
Forensic Toxicol; 2017; 35(2):369-375. PubMed ID: 28890736
[No Abstract] [Full Text] [Related]
12. Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.
Halberstadt AL
Curr Top Behav Neurosci; 2017; 32():283-311. PubMed ID: 28097528
[TBL] [Abstract][Full Text] [Related]
13. DARK Classics in Chemical Neuroscience: NBOMes.
Poulie CBM; Jensen AA; Halberstadt AL; Kristensen JL
ACS Chem Neurosci; 2020 Dec; 11(23):3860-3869. PubMed ID: 31657895
[No Abstract] [Full Text] [Related]
14. NBOMe: new potent hallucinogens--pharmacology, analytical methods, toxicities, fatalities: a review.
Kyriakou C; Marinelli E; Frati P; Santurro A; Afxentiou M; Zaami S; Busardo FP
Eur Rev Med Pharmacol Sci; 2015 Sep; 19(17):3270-81. PubMed ID: 26400534
[TBL] [Abstract][Full Text] [Related]
15. Effect of
Tirri M; Bilel S; Arfè R; Corli G; Marchetti B; Bernardi T; Boccuto F; Serpelloni G; Botrè F; De-Giorgio F; Golembiowska K; Marti M
Front Psychiatry; 2022; 13():875722. PubMed ID: 35530025
[TBL] [Abstract][Full Text] [Related]
16. 25X-NBOMe compounds - chemistry, pharmacology and toxicology. A comprehensive review.
Herian M; Świt P
Crit Rev Toxicol; 2023 Jan; 53(1):15-33. PubMed ID: 37115704
[TBL] [Abstract][Full Text] [Related]
17. Death after 25C-NBOMe and 25H-NBOMe consumption.
Morini L; Bernini M; Vezzoli S; Restori M; Moretti M; Crenna S; Papa P; Locatelli C; Osculati AMM; Vignali C; Groppi A
Forensic Sci Int; 2017 Oct; 279():e1-e6. PubMed ID: 28893436
[TBL] [Abstract][Full Text] [Related]
18. Application of a Urine and Hair Validated LC-MS-MS Method to Determine the Effect of Hair Color on the Incorporation of 25B-NBOMe, 25C-NBOMe and 25I-NBOMe into Hair in the Rat.
Nisbet LA; Venson R; Wylie FM; Scott KS
J Anal Toxicol; 2017 Jul; 41(6):559-565. PubMed ID: 28830123
[TBL] [Abstract][Full Text] [Related]
19. Hallucinogen-Like Action of the Novel Designer Drug 25I-NBOMe and Its Effect on Cortical Neurotransmitters in Rats.
Herian M; Wojtas A; Kamińska K; Świt P; Wach A; Gołembiowska K
Neurotox Res; 2019 Jul; 36(1):91-100. PubMed ID: 30989482
[TBL] [Abstract][Full Text] [Related]
20. Rapid Screening Method for New Psychoactive Substances of Forensic Interest: Electrochemistry and Analytical Determination of Phenethylamines Derivatives (NBOMe) via Cyclic and Differential Pulse Voltammetry.
Andrade AF; Mamo SK; Gonzalez-Rodriguez J
Anal Chem; 2017 Feb; 89(3):1445-1452. PubMed ID: 28059498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
